Nonclinical services for the development of interventional agents for infectious diseases
Ended Awarded Last action
- Contract number
- 75N93022F00002
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $218,000
Award facts
- Contract value 100% obligated
- $218,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
- National interest action
- Coronavirus COVID-19
Award details come from SAM.gov/FPDS.
About this award
This is a delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Curia Global Inc., doing business as Amri, for $218,000.00 in nonclinical services to support the development of interventional agents for infectious diseases. The contract is not set aside. Curia is a leading global contract development and manufacturing organization that provides a wide range of services from drug discovery through commercialization, including medicinal chemistry, chemical development, analytical testing, and other pharmaceutical research and development support services. This award is funded through the Coronavirus COVID-19 National Interest Action and contributes to the National Institute of Allergy and Infectious Diseases' therapeutic development initiatives in areas such as infectious diseases. The contract is a delivery order under the Nonclinical Services for Development of Interventional Agents master indefinite-delivery/indefinite-quantity contract vehicle.
Quick answers
Who was awarded contract 75N93022F00002?
75N93022F00002 was awarded to Curia Global Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 1, 2022.
How much is contract 75N93022F00002 worth?
The government has obligated $218,000 on 75N93022F00002.
Is contract 75N93022F00002 an order under another contract?
Yes. 75N93022F00002 is a delivery order under 75N93018D00008, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93022F00002 competed?
The extent of competition for 75N93022F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award